Dietary PUFA and flavonoids as deterrents for environmental pollutants

Journal of Nutritional Biochemistry

Volumn 18, Issue 3, 2007, Pages 196-205

  Watkins, Bruce A ^a,b   Hannon, Kevin ^b   Ferruzzi, Mario ^a   Li, Yong ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Flavonoids; Heavy metals; Inflammation; Omega 3 polyunsaturated fatty acids; Oxidative stress; Polychlorinated biphenyls

Indexed keywords

ANTIOXIDANT; BLOCHANIN A; CATECHIN; DAIDZEIN; DOCOSAHEXAENOIC ACID; EPICATECHIN; FERULIC ACID; FLAVONOID; GALLIC ACID; GARLIC EXTRACT; GENISTEIN; HEAVY METAL; LINOLEIC ACID; OMEGA 3 FATTY ACID; PARA COUMARIC ACID; PLACEBO; PLANT MEDICINAL PRODUCT; POLYCHLORINATED BIPHENYL; POLYUNSATURATED FATTY ACID; QUERCETIN; RESVERATROL; RUTOSIDE; UNCLASSIFIED DRUG; VINIFERIN;

ALLERGY; CANCER CELL; CARDIOVASCULAR DISEASE; CELL CULTURE; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DEMENTIA; DIET SUPPLEMENTATION; GENE TARGETING; HEAVY METAL POISONING; HUMAN; ISCHEMIC HEART DISEASE; LIFE CYCLE; MULTIPLE SCLEROSIS; MUSCLE ATROPHY; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPENIA; OXIDATIVE STRESS; REVIEW; TISSUE INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORONARY DISEASE; DIETARY FATS, UNSATURATED; ENVIRONMENTAL POLLUTANTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FLAVONOIDS; HUMANS; INFLAMMATION; LIPID METABOLISM; METALS, HEAVY; OXIDATIVE STRESS; POLYCHLORINATED BIPHENYLS;

ANIMALIA; RODENTIA;

EID: 33846805896     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.12.002     Document Type: Review

References (92)

1. Van Oostdam J., Donaldson S.G., Feeley M., Arnold D., Ayotte P., Bondy G., et al. Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ 351 (2005) 165-246
2. Dorea J.G., and Donangelo C.M. Early (in uterus and infant) exposure to mercury and lead. Clin Nutr 25 (2006) 369-376
3. Watanabe C. Modification of mercury toxicity by selenium: practical importance?. Tohoku J Exp Med 196 (2002) 71-77
4. Hennig B., Reiterer G., Majkova Z., Oesterling E., Meerarani P., and Toborek M. Modification of environmental toxicity by nutrients: implications in atherosclerosis. Cardiovasc Toxicol 5 (2005) 153-160
5. Hennig B., Hammock B.D., Slim R., Toborek M., Saraswathi V., and Robertson L.W. PCB-induced oxidative stress in endothelial cells: modulation by nutrients. Int J Hyg Environ Health 205 (2002) 95-102
6. Shahidi F. Functional foods: their role in health promotion and disease prevention. J Food Sci 69 (2004) R146-R149
7. Schreiner M., and Huyskens-Keil S. Phytochemicals in fruit and vegetables: health promotion and postharvest elicitors. Crit Rev Plant Sci 25 (2006) 267-278
8. Coxam W. New advances in osteoporosis nutritional prevention. Med Sci 21 (2005) 297-301
9. Kark J.D., Kaufmann N.A., Binka F., Goldberger N., and Berry E.M. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 77 (2003) 796-802
10. Yaqoob P., and Calder P.C. N-3 polyunsaturated fatty acids and inflammation in the arterial wall. Eur J Med Res 8 (2003) 337-354
11. Burdge G.C., and Calder P.C. Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev 19 (2006) 26-52
12. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81 (2005) 341-354
13. Dietary fats: total fat and fatty acids. Dietary reference intakes - energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (2002), The National Academies Press, Washington (DC) 8-1-8-97
14. Simopoulos A.P. Omega-6/omega-3 essential fatty acid ratio and chronic diseases. Food Rev Int 20 (2004) 77-90
15. Sirtori C.R., Crepaldi G., Manzato E., Mancini M., Rivellese A., Paoletti R., et al. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance reduced triglyceridemia, total cholesterol and increased hdl-c without glycemic alterations. Atherosclerosis 137 (1998) 419-427
16. Luo J., Rizkalla S.W., Vidal H., Oppert J.M., Colas C., Boussairi A., et al. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men - results of a controlled study. Diabetes Care 21 (1998) 717-724
17. Dunstan J.A., and Prescott S.L. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants?. Curr Opin Allergy Clin Immunol 5 (2005) 215-221
18. van Meeteren M.E., Teunissen C.E., Dijkstra C.D., and van Tol E.A.F. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr 59 (2005) 1347-1361
19. Baggio B., Musacchio E., and Priante G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J Nephrol 18 (2005) 362-367
20. Engler M.B., and Engler M.M. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64 (2006) 109-118
21. Ding E.L., Hutfless S.M., Ding X., and Girotra S. Chocolate and prevention of cardiovascular disease: a systematic review - art. no. 2. Nutr Metab 3 (2006) 2
22. Hamer M., and Steptoe A. Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br J Nutr 95 (2006) 849-859
23. Castilla P., Echarri R., Davalos A., Cerrato F., Ortega H., Teruel J.L., et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84 (2006) 252-262
24. Arteaga E., Villaseca P., Rojas A., Marshall G., and Bianchi M. Phytoestrogens possess a weak antioxidant activity on low density lipoprotein in contrast to the flavonoid quercetin in vitro in postmenopausal women. Climacteric 7 (2004) 397-403
25. Lekakis J., Rallidis L.S., Andreadou I., Vamvakou G., Kazantzoglou G., Magiatis P., et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 12 (2005) 596-600
26. Jalili T., Carlstrom J., Kim S., Freeman D., Jin H.F., Wu T.C., et al. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol 47 (2006) 531-541
27. Mennen L.I., Sapinho D., de Bree A., Arnault N., Bertrais S., Galan P., et al. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr 134 (2004) 923-926
28. Borek C. Garlic reduces dementia and heart-disease risk. J Nutr 136 (2006) 810S-812S
29. Rahman K., and Lowe G.M. Garlic and cardiovascular disease: a critical review. J Nutr 136 (2006) 736S-740S
30. Lau B.H.S. Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr 136 (2006) 765S-768S
31. Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol 16 (2006) 80-88
32. Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 49 (2005) 1063-1071
33. Karin M., Lawrence T., and Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124 (2006) 823-835
34. Taylor P.C., Williams R.O., and Feldmann M. Tumour necrosis factor [alpha] as a therapeutic target for immune-mediated inflammatory diseases. Curr Opin Biotechnol 15 (2004) 557-563
35. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 (2006) S3
36. Haringman J.J., Ludikhuize J., and Tak P.P. Chemokines in joint disease: the key to inflammation. Ann Rheum Dis 63 (2004) 1186-1194
37. Riva E., Grandi F., Massetto N., Radaelli G., Giovannini M., Zetterstrom R., et al. Polychlorinated biphenyls in colostral milk and visual function at 12 months of life. Acta Paediatr 93 (2004) 1103-1107
38. Kakela R., Kinnunen S., Kakela A., Hyvarinen H., and Asikainen J. Fatty acids, lipids, and cytochrome p-450 monooxygenase in hepatic microsomes of minks fed fish-based diets and exposed to Aroclor 1242. J Toxicol Environ Health 64 (2001) 427-446
39. Hennig B., Reiterer G., Toborek M., Matveev S.V., Daugherty A., Smart E., et al. Dietary fat interacts with PCBs to induce changes in lipid metabolism in mice deficient in low-density lipoprotein receptor. Environ Health Perspect 113 (2005) 83-87
40. Dhami M.S., Menon M., Aliling R., Afzal M., DiFonzo C.J., Ali B., et al. Effect of environmental pollutants on hepatocellular function in rats: 3-methylcholanthrene and Aroclor-1254. Drug Metabol Drug Interact 11 (1994) 283-299
41. Matsusue K., Ishii Y., Ariyoshi N., and Oguri K. A highly toxic PCB produces unusual changes in the fatty acid composition of rat liver. Toxicol Lett 91 (1997) 99-104
42. Kakela R., and Hyvarinen H. Fatty acid alterations caused by PCBs (Aroclor 1242) and copper in adipose tissue around lymph nodes of mink. Comp Biochem Physiol 122 (1999) 45-53
43. Grandjean P., and Weihe P. Arachidonic acid status during pregnancy is associated with polychlorinated biphenyl exposure. Am J Clin Nutr 77 (2003) 715-719
44. Bae J., Peters-Golden M., and Loch-Caruso R. Stimulation of pregnant rat uterine contraction by the polychlorinated biphenyl (PCB) mixture aroclor 1242 may be mediated by arachidonic acid release through activation of phospholipase A(2) enzymes. J Pharmacol Exp Ther 289 (1999) 1112-1120
45. Kodavanti P.R., and Derr-Yellin E.C. Differential effects of polybrominated diphenyl ethers and polychlorinated biphenyls on [3H]arachidonic acid release in rat cerebellar granule neurons. Toxicol Sci 68 (2002) 451-457
46. Sanchez E., Fernandez S.M., Lopez-Aparicio P., Recio M.N., and Perez-Albarsanz M.A. Selective fatty acid release from intracellular phospholipids caused by PCBs in rat renal tubular cell cultures. Chem Biol Interact 125 (2000) 117-131
47. Slim R., Hammock B.D., Toborek M., Robertson L.W., Newman J.W., Morisseau C.H., et al. The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicol Appl Pharmacol 171 (2001) 184-193
48. Hennig B., Slim R., Toborek M., and Robertson L.W. Linoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells. J Biochem Mol Toxicol 13 (1999) 83-91
49. Tithof P.K., Schiamberg E., Peters-Golden M., and Ganey P.E. Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls. Environ Health Perspect 104 (1996) 52-58
50. Senthil Kumar J., Banudevi S., Sharmila M., Murugesan P., Srinivasan N., Balasubramanian K., et al. Effects of vitamin C and E on PCB (Aroclor 1254) induced oxidative stress, androgen binding protein and lactate in rat Sertoli cells. Reprod Toxicol 19 (2004) 201-208
51. Tharappel J.C., Lee E.Y., Robertson L.W., Spear B.T., and Glauert H.P. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol Appl Pharmacol 179 (2002) 172-184
52. Choi W., Eum S.Y., Lee Y.W., Hennig B., Robertson L.W., and Toborek M. PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci 75 (2003) 47-56
53. Bezdecny S.A., Roth R.A., and Ganey P.E. Effects of 2,2′,4,4′-tetrachlorobiphenyl on granulocytic HL-60 cell function and expression of cyclooxygenase-2. Toxicol Sci 84 (2005) 328-334
54. Mariussen E., Myhre O., Reistad T., and Fonnum F. The polychlorinated biphenyl mixture aroclor 1254 induces death of rat cerebellar granule cells: the involvement of the N-methyl-d-aspartate receptor and reactive oxygen species. Toxicol Appl Pharmacol 179 (2002) 137-144
55. Ramadass P., Meerarani P., Toborek M., Robertson L.W., and Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci 76 (2003) 212-219
56. Venkataraman P., Sridhar M., Dhanammal S., Vijayababu M.R., Srinivasan N., and Arunakaran J. Antioxidant role of zinc in PCB (Aroclor 1254) exposed ventral prostate of albino rats. J Nutr Biochem 15 (2004) 608-613
57. Guallar E., Sanz-Gallardo M.I., van't Veer P., Bode P., Aro A., Gomez-Aracena J., et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347 (2002) 1747-1754
58. Donaldson W.E., and Leeming T.K. Dietary lead: effects on hepatic fatty acid composition in chicks. Toxicol Appl Pharmacol 73 (1984) 119-123
59. Kafer A., Zoltzer H., and Krug H.F. The stimulation of arachidonic acid metabolism by organic lead and tin compounds in human HL-60 leukemia cells. Toxicol Appl Pharmacol 116 (1992) 125-132
60. Kafer A., and Krug H.F. Effects of organometals on cellular signaling. I. Influence of metabolic inhibitors on metal-induced arachidonic acid liberation. Environ Health Perspect 102 (1994) 325-330
61. Turner S.R., Turner R.A., Smith D.M., and Johnson J.A. Effects of heavy metal ions on phospholipid metabolism in human neutrophils: relationship to ionophore-mediated cytotoxicity. Prostaglandins 32 (1986) 919-930
62. Gunnarsson D., Svensson M., Selstam G., and Nordberg G. Pronounced induction of testicular PGF(2 alpha) and suppression of testosterone by cadmium-prevention by zinc. Toxicology 200 (2004) 49-58
63. Figueiredo-Pereira M.E., Li Z., Jansen M., and Rockwell P. N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells. J Biol Chem 277 (2002) 25283-25289
64. Howlett N.G., and Avery S.V. Induction of lipid peroxidation during heavy metal stress in Saccharomyces cerevisiae and influence of plasma membrane fatty acid unsaturation. Appl Environ Microbiol 63 (1997) 2971-2976
65. Ito Y., Niiya Y., Kurita H., Shima S., and Sarai S. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int Arch Occup Environ Health 56 (1985) 119-127
66. Ercal N., Gurer-Orhan H., and Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 1 (2001) 529-539
67. Foran S.E., Flood J.G., and Lewandrowski K.B. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?. Arch Pathol Lab Med 127 (2003) 1603-1605
68. Bjerregaard P. Cardiovascular disease and environmental pollutants: the Arctic aspect. Arctic Med Res 55 (1996) 25-31
69. 2 and invasiveness in MDA-MB-231 breast cancer cells. Carcinogenesis (2006) [epub ahead of press]
70. Munoz-Espada A.C., and Watkins B.A. Cyanidin attenuates PGE(2) production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 17 (2006) 589-596
71. Neilson A.P., Li Y., Hannon K., Ferruzzi M.G., and Watkins B.A. Accumulation of catechins in bone and liver of mice fed green tea while under physical stress. FASEB J 20 (2006) A570
72. Stahl W., van den B.H., Arthur J., Bast A., Dainty J., Faulks R.M., et al. Bioavailability and metabolism. Mol Aspects Med 23 (2002) 39-100
73. Gangloff M.B., Glahn R.P., Miller D.D., and Vancampen D.R. Assessment of iron availability using combined in vitro digestion and caco-2 cell culture. Nutr Res 16 (1996) 479-487
74. Larsson M., Minekus M., and Havenaar R. Estimation of the bioavailability of iron and phosphorus in cereals using a dynamic in vitro gastrointestinal model. J Sci Food Agric (1997) 99-106
75. Yun S., Habicht J.P., Miller D.D., and Glahn R.P. An in vitro digestion/Caco-2 cell culture system accurately predicts the effects of ascorbic acid and polyphenolic compounds on iron bioavailability in humans. J Nutr (2004) 2717-2721
76. Fouad F.M., Farrell P.G., Marshall W.D., and Van de Voort F.R. In vitro model for lipase-catalyzed lipophile release from fats. J Agric Food Chem (1991) 150-153
77. Ferruzzi M.G., Lumpkin J.L., Schwartz S.J., and Failla M. Digestive stability, micellarization, and uptake of beta-carotene isomers by Caco-2 human intestinal cells. J Agric Food Chem (2006) 2780-2785
78. Garrett D.A., Failla M.L., and Sarama R.J. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J Agric Food Chem (1999) 4301-4309
79. Garrett D.A., Failla M.L., and Sarama R.J. Estimation of carotenoid bioavailability from fresh stir-fried vegetables using an in vitro digestion/Caco-2 cell culture model. J Nutr Biochem 11 (2000) 574-580
80. Liu C.S., Glahn R.P., and Liu R.H. Assessment of carotenoid bioavailability of whole foods using a Caco-2 cell culture model coupled with an in vitro digestion. J Agric Food Chem (2004) 4330-4337
81. Ferruzzi M.G., Failla M.L., and Schwartz S.J. Assessment of degradation and intestinal cell uptake of carotenoids and chlorophyll derivatives from spinach puree using an in vitro digestion and Caco-2 human cell model. J Agric Food Chem (2001) 2082-2089
82. Ferruzzi M.G., Failla M.L., and Schwartz S.J. Sodium copper chlorophyllin: in vitro digestive stability and accumulation by Caco-2 human intestinal cells. J Agric Food Chem (2002) 2173-2179
83. Green R.J., and Ferruzzi M.G. Food matrix factors affecting stability of green tea catechins during simulated digestion. FASEB J 20 (2006) A153
84. McDougall G.J., Dobson P., Smith P., Blake A., and Stewart D. Assessing potential bioavailability of raspberry anthocyanins using an in vitro digestion system. J Agric Food Chem (2005) 5896-5904
85. Record I.R., and Lane J.M. Simulated intestinal digestion of green and black teas. Food Chem 73 (2001) 481-486
86. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47 (1983) 323-330
87. Gan L.S.L., and Thakker D.R. Applications of the caco-2 model in the design and development of orally active drugs - elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv Drug Deliv Rev 23 (1997) 77-98
88. Hidalgo I.J., and Li J.B. Carrier-mediated transport and efflux mechanisms in caco-2 cells. Adv Drug Deliv Rev 22 (1996) 53-66
89. Sambuy Y., Angelis I., Ranaldi G., Scarino M.L., Stammati A., and Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21 (2005) 1-26
90. Lennernas H., Palm K., Fagerholm U., and Artursson P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int J Pharm 127 (1996) 103-107
91. Vaidyanathan J.B., and Walle T. Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 307 (2003) 745-752
92. Zhang L., Zheng Y., Chow M.S.S., and Zuo Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int J Pharm 287 (2004) 1-12